Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
Spinal and bulbar muscular atrophy (SBMA) is the first member identified among polyglutamine diseases characterized by slowly progressive muscle weakness and atrophy of the bulbar, facial, and limb muscles pathologically associated with motor neuron loss in the spinal cord and brainstem. Androgen re...
Saved in:
Main Authors: | Fumiaki Tanaka, Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Hiroaki Adachi, Gen Sobue |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2012/369284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Previously Undiagnosed Spinal and Bulbar Muscular Atrophy as a Cause of Airway Obstruction after Robot-Assisted Laparoscopic Prostatectomy
by: Miyuki Niki, et al.
Published: (2017-01-01) -
Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families
by: Shanshan Gao, et al.
Published: (2025-01-01) -
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
by: Hooi Ling Teoh, et al.
Published: (2017-01-01) -
Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
by: Hiangkiat Tan, et al.
Published: (2019-12-01) -
COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome
by: Rafat Mosalli, et al.
Published: (2021-01-01)